ACCELERON PHARMA INC Uncategorized Contracts & Agreements
10 Contracts & Agreements
- Offer Letter between Jay T. Backstrom, M.D., M.P.H. and Acceleron Pharma Inc., dated as of December 4, 2019 (Filed With SEC on February 25, 2021)
- Offer Letter between Robert K. Zeldin and Acceleron Pharma Inc., dated as of June 15, 2018 (Filed With SEC on February 27, 2019)
- Offer Letter between Sujay Kango and Acceleron Pharma Inc., dated as of December 29, 2017 (Filed With SEC on February 27, 2019)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on March 1, 2017)
- EXHIBIT A ACCELERON PHARMA INC. PERSONNEL VESTING SUMMARY AS OF DECEMBER 1, 2016 JOHN L. KNOPF (Filed With SEC on November 3, 2016)
- [Rest of page intentionally left blank.] (Filed With SEC on September 27, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on August 4, 2016)
- THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST.REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES... (Filed With SEC on August 4, 2016)
- ACTRIIB AMENDMENT (Filed With SEC on August 12, 2014)
- RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT (AMENDED AND RESTATED AS OF DECEMBER 22, 2011) (Filed With SEC on August 7, 2013)
